| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $20,168,684 ) (Continued on the next page) |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R03AI199486 | Glucose and glutamine transport: novel targets in cystic fibrosis immune responses | 000 | 1 | NIH | 7/1/2026 | $164,350 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R13HL186683 | Pulmonary Vascular Disease: The Vascular Niche and its Interactions in Lung Homeostasis and Disease | 000 | 1 | NIH | 6/1/2026 | $30,000 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21AR085863 | Novel Models to Define the Role of Aberrant T Cell Subsets in Scleroderma Pulmonary Fibrosis | 000 | 1 | NIH | 6/3/2026 | $388,025 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort: Deciphering the role of early life skin dysfunction in development of the allergic march | 000 | 3 | NIH | 7/7/2026 | $1,310,726 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 001 | 7 | NIH | 5/1/2026 | $4,361,109 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI189915 | Prenatal programming of immune cells for tissue repair and remodeling in asthma | 000 | 1 | NIH | 2/19/2026 | $776,394 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21CA301519 | MDS-associated U2AF1 mutations induce natural killer cell dysfunction | 000 | 1 | NIH | 4/2/2026 | $435,062 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21AI196335 | Uncovering the role of resident memory T cell in chronic lung disease viral infections | 000 | 1 | NIH | 2/4/2026 | $470,219 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL177550 | Role of the SFTA2/ADGRF5 signaling axis in alveolar homeostasis | 000 | 2 | NIH | 7/29/2026 | $655,721 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 001 | 7 | NIH | 4/17/2026 | $330,358 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 001 | 5 | NIH | 4/29/2026 | $29,879 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 000 | 5 | NIH | 2/3/2026 | $946,200 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 Jackson Street | Denver | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 00 | 3 | HRSA | 7/16/2026 | $215,581 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL169897 | Rare Airway Cell Function in Post-Viral Chronic Inflammation | 000 | 3 | NIH | 7/27/2026 | $249,000 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 000 | 3 | NIH | 3/25/2026 | $665,180 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL166938 | Interaction of fibroblasts with cell corpses increases collagen synthesis during lung repair | 000 | 4 | NIH | 7/7/2026 | $610,978 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL162955 | Molecular Characterization of Progressive Pulmonary Sarcoidosis | 000 | 4 | NIH | 8/19/2026 | $767,210 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL167956 | GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection | 000 | 4 | NIH | 4/28/2026 | $608,223 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01ES033678 | Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | 000 | 5 | NIH | 12/30/2025 | $556,630 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 000 | 4 | NIH | 2/27/2026 | $685,103 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08ES034820 | Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | 000 | 4 | NIH | 1/15/2026 | $165,888 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 000 | 7 | NIH | 8/10/2026 | $574,768 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM137961 | Discovery of Novel Mechanisms of Action of Ubiquitin-Like Proteins in Cellular Stress Pathways | 001 | 6 | NIH | 5/1/2026 | $456,500 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 5 | NIH | 2/16/2026 | $158,328 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 3 | NIH | 12/22/2025 | $114,626 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI182277 | Mast Cell Lineage Commitment and Function | 000 | 2 | NIH | 12/1/2025 | $614,256 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 002 | 3 | NIH | 7/20/2026 | $0 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 001 | 3 | NIH | 2/6/2026 | $52,628 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 000 | 3 | NIH | 1/30/2026 | $473,648 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 003 | 6 | NIH | 2/16/2026 | $250,000 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 002 | 6 | NIH | 2/9/2026 | $165,000 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL168278 | Reparative functions of human airspace macrophage subsets | 000 | 3 | NIH | 7/8/2026 | $590,895 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 Jackson Street | Denver | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 01 | 24 | HRSA | 7/22/2026 | $47,978 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 00 | 24 | HRSA | 6/17/2026 | $776,086 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL186673 | Termination of lung inflammation by MyD88 alternative splicing | 000 | 1 | NIH | 7/16/2026 | $1,559,468 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 000 | 2 | NIH | 8/10/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 13 | NIH | 12/3/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 5 | NIH | 2/10/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 6 | NIH | 3/26/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 05 | 2 | HRSA | 7/24/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 04 | 2 | HRSA | 3/13/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 03 | 2 | HRSA | 11/21/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 02 | 2 | HRSA | 11/13/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 000 | 4 | NIH | 5/20/2026 | -$22,145 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 000 | 5 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173239 | Integrative Metabolomics of Sarcoidosis Diagnosis and Progression | 000 | 1 | NIH | 8/13/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 004 | 5 | NIH | 2/16/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 001 | 5 | NIH | 1/14/2026 | $237,651 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 5 | NIH | 12/10/2025 | $0 |
|
